{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.272","meta":{"versionId":"3","lastUpdated":"2015-11-26T01:00:03.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.272","version":"20151126","name":"EGFR Inhibitor","status":"active","date":"2015-11-26T01:00:03-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1160730","display":"panitumumab Injectable Product"},{"code":"1161239","display":"cetuximab Injectable Product"},{"code":"1168274","display":"Erbitux Injectable Product"},{"code":"1187748","display":"Vectibix Injectable Product"},{"code":"263034","display":"panitumumab"},{"code":"318341","display":"cetuximab"},{"code":"355460","display":"Erbitux"},{"code":"485253","display":"cetuximab 2 MG/ML"},{"code":"544717","display":"cetuximab 2 MG/ML [Erbitux]"},{"code":"667879","display":"panitumumab 20 MG/ML"},{"code":"667895","display":"panitumumab 20 MG/ML [Vectibix]"},{"code":"675979","display":"Vectibix"}]}]}}